|
CN112023038A
|
|
Compound immunopotentiator
|
|
CN110438205A
|
|
Joint multiplex PCR nest-type PRC and touchdown PCR are used for the kit of pathogenic mycobacterium tuberculosis detection
|
|
CN110522906A
|
|
Multidimensional, multivalence, the preparation method of prostatic cancer specific tumour antigen assembly
|
|
CN110273001A
|
|
One kind circRNA relevant to prostate cancer and its application
|
|
CN110237048A
|
|
Magnetism/n-trimethyl chitosan chloride nanoparticle and its preparation method and application of PEG modification with peroxidase activity
|
|
CN110229359A
|
|
UiO-66(NH2) chitosan composite antibiotic film and its preparation method and application
|
|
CN108866052A
|
|
Application of the AR-V7 variable sheer sequence in anti-castration-resistant tumour
|
|
CN106932567A
|
|
A kind of preparation method of the immune targeted nano gold of recombinant protein A mediation
|
|
CN106405085A
|
|
ELISA kit used for detecting castration-resistant prostate cancer and using method thereof
|
|
CN106290919A
|
|
For detecting ELISA kit and the using method of castration-resistant prostate cancer
|
|
CN106198985A
|
|
For detecting ELISA kit and the using method of castration-resistant prostate cancer
|
|
CN105368931A
|
|
Method for detecting exosome-derived miRNAs biomarkers in urine
|
|
CN104237535A
|
|
Application of neurotensin in diagnosis on castration resistant prostate cancer neuroendocrine subtype and prognosis judgment
|
|
CN104131088A
|
|
Method for analyzing influences of E2F3 gene slicing on whole blood E2F3 in prostate cancer animal model
|
|
CN103210879A
|
|
Construction method of human prostatic cancer fresh tissue hormone-independent prostatic cancer nude mouse model
|
|
CN102086473A
|
|
Undirected network screening method for key genes of human polygenic disease
|
|
CN101275148A
|
|
PAMAM-D mediated sperm vector method for cultivating transgenic mammalian
|
